Evidence map›Paper›PMID 37330506›Full record

ArticleRespiratory research2023

Alveolar macrophages from EVALI patients and e-cigarette users: a story of shifting phenotype.

Kristi J Warren, Emily M Beck, Sean J Callahan, My N Helms, Elizabeth Middleton, Sean Maddock, Jason R Carr, Dixie Harris, Denitza P Blagev, Michael J Lanspa and 2 more

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  3. The effects of flavored vaped e-liquids on cultured human macrophages derived from the central and peripheral nervous systems.Toxicology in vitro : an international journal published in association with BIBRA · 2025
    Article
  4. Secondhand vape exposure regulation of CFTR and immune function in cystic fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Kristi J Warren *Department of Internal Medicine, Division of Pulmonary & Critical Care Medicine, University of Utah, Salt Lake City, UT, 84132, USA. kristi.warren@hsc.utah.edu.
Emily M Beck *Department of Internal Medicine, Division of Pulmonary & Critical Care Medicine, University of Utah, Salt Lake City, UT, 84132, USA.
Sean J Callahan *Department of Internal Medicine, Division of Pulmonary & Critical Care Medicine, University of Utah, Salt Lake City, UT, 84132, USA.
My N HelmsDepartment of Internal Medicine, Division of Pulmonary & Critical Care Medicine, University of Utah, Salt Lake City, UT, 84132, USA.
Elizabeth MiddletonDepartment of Internal Medicine, Division of Pulmonary & Critical Care Medicine, University of Utah, Salt Lake City, UT, 84132, USA.
Sean MaddockGeorge E. Wahlen VA Medical Center, 500 Foothill Dr, Salt Lake City, UT, 84148, USA.
Jason R CarrDepartment of Internal Medicine, Division of Pulmonary & Critical Care Medicine, University of Utah, Salt Lake City, UT, 84132, USA.
Dixie HarrisIntermountain Healthcare, Department of Pulmonary & Critical Care Medicine, Murray, UT, 84107, USA.
Denitza P BlagevIntermountain Healthcare, Department of Pulmonary & Critical Care Medicine, Murray, UT, 84107, USA.
Michael J LanspaIntermountain Healthcare, Department of Pulmonary & Critical Care Medicine, Murray, UT, 84107, USA.
Samuel M BrownIntermountain Healthcare, Department of Pulmonary & Critical Care Medicine, Murray, UT, 84107, USA.
Robert PaineDepartment of Internal Medicine, Division of Pulmonary & Critical Care Medicine, University of Utah, Salt Lake City, UT, 84132, USA.
University of Utah · USIntermountain Healthcare · USGeorge E. Wahlen Department of VA Medical Center · USUniversity of Colorado Denver · US

Funding

ZINC GLUCONATE GLYCINE LOZENGES &VITAMIN C EFFECTS ON COMMON COLDM01RR000042 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YANIK, GREGORY A · 1985 to 2007
$40.8M
Multidisciplinary Pulmonary and Critical Care Training ProgramT32HL105321 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Ramsey Hachem, Robert Paine · 2010 to 2026
$4.5M
Long Term Outcomes and Macrophage Biology in Patients with EVALIU01HL123018 · NHLBI · IHC HEALTH SERVICES, INC. · PI BLEDSOE, JOSEPH R, BROWN, SAMUEL MORRIS · 2014 to 2020
$2.4M
Oxygen, Pulmonary Innate Immunity and Alveolar Epithelial Cell GM-CSFI01BX001777 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI PAINE, ROBERT · 2013 to 2023
–
Migration and signaling in ILC2 in asthma: Male and female differencesIK2BX004219 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI WARREN, KRISTI J · 2020 to 2025
–
BLRD VA I01 BX001777BLRD VA IK2 BX004219NCRR NIH HHS M01 RR000042NHLBI NIH HHS U01 HL123018NIH HHS 5T32HL105321NIH HHS U01HL123018-06S1
6 · The paper itself

Abstract

Exposure to e-cigarette vapors alters important biologic processes including phagocytosis, lipid metabolism, and cytokine activity in the airways and alveolar spaces. Little is known about the biologic mechanisms underpinning the conversion to e-cigarette, or vaping, product use-associated lung injury (EVALI) from normal e-cigarette use in otherwise healthy individuals. We compared cell populations and inflammatory immune populations from bronchoalveolar lavage fluid in individuals with EVALI to e-cigarette users without respiratory disease and healthy controls and found that e-cigarette users with EVALI demonstrate a neutrophilic inflammation with alveolar macrophages skewed towards inflammatory (M1) phenotype and cytokine profile. Comparatively, e-cigarette users without EVALI demonstrate lower inflammatory cytokine production and express features associated with a reparative (M2) phenotype. These data indicate macrophage-specific changes are occurring in e-cigarette users who develop EVALI.

Indexed as

Biological ProductsElectronic Nicotine Delivery SystemsLung InjuryCytokinesHumansMacrophages, AlveolarPhenotypeBiological ProductsCytokinesAlveolar macrophages (AM)Bronchoalveolar lavage (BAL)E-cigaretteOr vapingProduct use-associated lung injury (EVALI)

Identifiers

PMID37330506
PMCPMC10276465
OpenAlexW4381094334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.